NDC 13668-281

Pioglitazone HCL and Metformin HCL

Pioglitazone Hcl And Metformin Hcl

Pioglitazone HCL and Metformin HCL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Metformin Hydrochloride; Pioglitazone Hydrochloride.

Product ID13668-281_0c4f8813-a996-4d23-a1c4-cd7d111272f8
NDC13668-281
Product TypeHuman Prescription Drug
Proprietary NamePioglitazone HCL and Metformin HCL
Generic NamePioglitazone Hcl And Metformin Hcl
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-02-13
Marketing CategoryANDA / ANDA
Application NumberANDA202001
Labeler NameTorrent Pharmaceuticals Limited
Substance NameMETFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Active Ingredient Strength850 mg/1; mg/1
Pharm ClassesBiguanide [EPC],Biguanides [CS],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 13668-281-74

100 TABLET in 1 CARTON (13668-281-74)
Marketing Start Date2013-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13668-281-05 [13668028105]

Pioglitazone HCL and Metformin HCL TABLET
Marketing CategoryANDA
Application NumberANDA202001
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-13

NDC 13668-281-49 [13668028149]

Pioglitazone HCL and Metformin HCL TABLET
Marketing CategoryANDA
Application NumberANDA202001
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-13

NDC 13668-281-60 [13668028160]

Pioglitazone HCL and Metformin HCL TABLET
Marketing CategoryANDA
Application NumberANDA202001
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-02-13

NDC 13668-281-74 [13668028174]

Pioglitazone HCL and Metformin HCL TABLET
Marketing CategoryANDA
Application NumberANDA202001
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-02-13

NDC 13668-281-33 [13668028133]

Pioglitazone HCL and Metformin HCL TABLET
Marketing CategoryANDA
Application NumberANDA202001
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-02-13

Drug Details

Active Ingredients

IngredientStrength
METFORMIN HYDROCHLORIDE850 mg/1

OpenFDA Data

SPL SET ID:237d8fa2-633c-4c29-84d3-f1b413610dc3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 861783
  • 861822
  • UPC Code
  • 0313668280050
  • 0313668281057
  • Pharmacological Class

    • Biguanide [EPC]
    • Biguanides [CS]
    • Peroxisome Proliferator-activated Receptor Activity [MoA]
    • PPAR alpha [CS]
    • PPAR gamma [CS]
    • Thiazolidinedione [EPC]
    • Thiazolidinediones [CS]
    • Peroxisome Proliferator Receptor alpha Agonist [EPC]
    • Peroxisome Proliferator Receptor gamma Agonist [EPC]
    • Biguanide [EPC]
    • Biguanides [CS]
    • Peroxisome Proliferator-activated Receptor Activity [MoA]
    • PPAR alpha [CS]
    • PPAR gamma [CS]
    • Thiazolidinedione [EPC]
    • Thiazolidinediones [CS]
    • Peroxisome Proliferator Receptor alpha Agonist [EPC]
    • Peroxisome Proliferator Receptor gamma Agonist [EPC]

    Medicade Reported Pricing

    13668028160 PIOGLITAZONE-METFORMIN 15-850

    Pricing Unit: EA | Drug Type:

    13668028133 PIOGLITAZONE-METFORMIN 15-850

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Pioglitazone HCL and Metformin HCL" or generic name "Pioglitazone Hcl And Metformin Hcl"

    NDCBrand NameGeneric Name
    13668-280Pioglitazone HCL and Metformin HCLPioglitazone HCL and Metformin HCL
    13668-281Pioglitazone HCL and Metformin HCLPioglitazone HCL and Metformin HCL

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.